Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)
| Autor: | Zhao, Hongyun, Yao, Wenxiu, Min, Xuhong, Gu, Kangsheng, Yu, Guohua, Zhang, Zhonghan, Cui, Jiuwei, Miao, Liyun, Zhang, Li, Yuan, Xia, Fang, Yong, Fu, Xiuhua, Hu, Chengping, Zhu, Xiaoli, Fan, Yun, Yu, Qitao, Wu, Gang, Jiang, Ou, Du, Xiuping, Liu, Jiwei, Gu, Wei, Hou, Zhiguo, Wang, Quanren, Zheng, Rongrong, Zhou, Xianfeng |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology September 2021 16(9):1533-1546 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|